Skip to main content

Table 1 Characteristics of the study groups

From: Dynamics of resistance mutations to NS3 protease inhibitors in a cohort of Brazilian patients chronically infected with hepatitis C virus (genotype 1) treated with pegylated interferon and ribavirin: a prospective longitudinal study

Patient Characteristics

SVR (n = 26)

REL (n = 10)

NR (n = 32)

Total (n = 68)

Median Age

54.00

56.00

56.00

55.00

Median BMI

25.96

27.15

24.58

25.49

Male (%)

62

40

56

56

  1. REL, Relapsing; NR, Non-Responder; SVR, Sustained Virological Response; BMI, Body Mass Index.
  2. No statistically significant differences were observed between the SVR, REL and NR groups (p > 0.4, G-test and Chi-square test).